Hyaluronic Acid Viscosupplementation | Market Insights | Global | 2024
The HA viscosupplementation market was negatively impacted during the COVID-19 pandemic due to the postponement of elective treatments. Nevertheless, with the easing of restrictions and the increase in vaccination rates, the market has shown signs of recovery. Factors such as favorable demographics, increased patient awareness, improved physician training, effective marketing efforts by companies, and ongoing product innovation will contribute to the modest growth of the HA viscosupplementation market. Furthermore, premium-priced 1-injection products will continue to become more popular over the forecast period, whereas 3- and 5-injection products will continue to be preferred in some countries due to differences in product access, cost, and reimbursement.
This Medtech 360 Report provides comprehensive data and analysis on the state of the market for HA viscosupplementation in the US, Europe, Asia Pacific, and Brazil from 2019 through 2032.
